Welcome to our book review site go-pdf.online!

You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.

Sign up

Novel Psychoactive Drugs
  • Language: en
  • Pages: 196

Novel Psychoactive Drugs

An increasing number of novel psychoactive drugs are currently available and sold as 'legal highs' or 'research chemicals'. These New Psychoactive Substances (NPS) constitute a broad range of hundreds of natural and synthetic drugs, including synthetic cannabinoids, synthetic cathinones, synthetic opioids and other classes, which use has resulted in a significantly growing number of intoxication and mortality, as reported by emergency and poison centres from all over the world. Definition of “NPS” includes any substance that has recently become available and has been designed purposely to replace illegal drugs, although not necessarily of new synthesis. Use of NPS is dramatically increas...

Addiction and the Brain: Current Knowledge, Methods, and Perspectives
  • Language: en
  • Pages: 166
Melatonin
  • Language: en
  • Pages: 576

Melatonin

  • Type: Book
  • -
  • Published: 2014-10-15
  • -
  • Publisher: CRC Press

There is growing interest in the field of melatonin research regarding its neurobiological mechanisms as well as its repercussions in clinical practice. Melatonin: Therapeutic Value and Neuroprotection explores melatonin’s neuroprotective effects and discusses the therapeutic potential of melatonin and melatonin agonists in treating neurodegenerative diseases and other ailments. Topics include: The basic aspects of melatonin’s physiology, including its production, bioavailability, and metabolism The functional importance of melatonin receptors and their role in mediating the therapeutic effectiveness of melatonin in cancer Melatonin’s effect on the regulation of blood pressure, sleep, ...

Mobile and Wearable Systems for Health Monitoring
  • Language: en
  • Pages: 156
Individual Differences in Addictive Behaviors
  • Language: en
  • Pages: 137

Individual Differences in Addictive Behaviors

The study of addiction draws primarily on methods and approaches to understanding, treating and supporting addiction drawn from traditional approaches. The foundations of which focus on responses seen across groups, but often neglecting to account for the role the individual differences plays in understanding and treating addiction. It is clear from the literature that there is often a lack of consensus in both understanding and treating those struggling with addiction. Individual differences therefore, whilst not always conforming to the accepted model for developing theoretical interpretations and practice in the field, are key to successful outcomes in treating addiction.

Neurobiological Perspectives in Behavioral Addiction
  • Language: en
  • Pages: 187

Neurobiological Perspectives in Behavioral Addiction

Some classes of behaviors, including gambling, Internet gaming, and sexual behaviors, may lead to compulsive engagement for a minority of individuals. In extreme cases where individuals may feel unable to control these behaviors without external influence, these behaviors may be considered non-substance or behavioral addictions. Many such behaviors may occur predominantly online, such as gaming, social media, shopping, and pornography, and may be driven by constant accessibility via smartphone and other mobile device technologies. This Research Topic presents diverse papers on neurobiological evidence of behavioral addictions, encompassing gambling disorder, Internet-based disorders, including Internet gaming disorder and smartphone addiction, and compulsive sexual behaviors.

Cognitive Enhancement in Psychiatric Disorders
  • Language: en
  • Pages: 261

Cognitive Enhancement in Psychiatric Disorders

Disturbances of various domains of cognitive function have been shown to provide a major determinant of outcome for patients with psychiatric conditions. Cognitive impairment is present in an array of diseases, including schizophrenia (with its prodromal stage), mood disorder, autism spectrum disorder, obsessive-compulsive disorder, anxiety disorder, post-traumatic disorder, and eating disorder. In an effort to develop effective therapeutics for cognitive impairment, bridging of preclinical and clinical evidence has been attempted. This edited Book will provide a forum for researchers and clinicians interested in the phenomenology, underlying mechanisms, and treatment of cognitive impairment associated with psychiatric illnesses. Twenty-eight contributions from 8 countries in Europe, Middle East, Asia, North America, and South America represent studies dealing with genetic, molecular, imaging, physiological, psychological, and behavioral issues. Information in this Book will facilitate the development of therapeutics of greater clinical value.